What is Revvity, Inc.'s earnings per share (EPS)?

Revvity, Inc. (RVTY) reported diluted earnings per share of $2.07 for fiscal year 2025. This represents a -5.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Revvity, Inc. (RVTY) Financials

RVTY

Trailing 12 months to July 5, 2026

Revenue $2.9B +4.1% YoY

Net Income $237.6M -16.7% YoY

EPS (Diluted) $2.09 -11.4% YoY

Free Cash Flow $558.1M +11.0% YoY

Market Cap $17.4B as of Oct 12, 2026

Price / Sales 6.0x on $2.9B revenue, trailing 12 months to July 5, 2026

Price / Earnings 73.1x on $237.6M net income, trailing 12 months to July 5, 2026

Price / Book 2.4x on $7.2B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 5, 2026 Reported Aug 11, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RVTY SEC filings page.

Revvity, Inc. (RVTY) reported $2.9B in revenue over the twelve months to Jul 5, 2026, up 4.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RVTY FY2025 2026-10-03

Revvity’s cash generation has recovered, but revenue growth has not restored its much higher operating profitability seen in FY2021.

The 2023 trough was a cash-flow problem as well as a profit problem: operating cash flow fell to $92M and free cash flow to $9.9M, then both recovered by FY2024. In FY2025, free cash flow of $509M exceeded net income of $241M, a gap consistent with substantial non-cash charges rather than margin expansion alone.

Revenue recovered only modestly from $2.75B in FY2023 to $2.86B in FY2025, so scale has not returned to its earlier earnings profile. Operating margin was 12.5% in FY2025 versus 32.9% in FY2021, indicating a structurally lower profit capture per sales dollar.

Long-term leverage has eased: debt-to-equity fell from 0.7x in FY2021 to 0.4x in FY2025, reducing balance-sheet dependence on debt. Yet current ratio dropped from 3.6x in FY2024 to 1.7x in FY2025, showing that short-term flexibility narrowed even as long-term leverage improved.

Financial Health Signals

Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Revvity, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Revvity, Inc. has an operating margin of 12.5%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is down from 12.6% the prior year.

Growth

Revvity, Inc.'s revenue grew a modest 3.7% year-over-year to $2.9B. This slow but positive growth earns a score of 37/100.

Leverage

Revvity, Inc. has elevated debt relative to equity (D/E of 0.36), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 29/100, reflecting increased financial risk.

Liquidity

Revvity, Inc.'s current ratio of 1.68 indicates adequate short-term liquidity, earning a score of 49/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Revvity, Inc. converts 17.8% of revenue into free cash flow ($509.4M). This strong cash generation earns a score of 78/100.

Returns

Revvity, Inc.'s ROE of 3.3% shows moderate profitability relative to equity, earning a score of 45/100. This is down from 3.5% the prior year.

Altman Z-Score Safe

3.24

Revvity, Inc. scores 3.24, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($17.4B) relative to total liabilities ($4.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Revvity, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.42x

For every $1 of reported earnings, Revvity, Inc. generates $2.42 in operating cash flow ($582.9M OCF vs $241.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.87x

Revvity, Inc. earns $3.87 in operating income for every $1 of interest expense ($356.6M vs $92.2M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$729.7M

YoY+4.4%

QoQ+2.6%

5Y CAGR-6.6%

10Y CAGR+3.3%

Revvity, Inc. generated $729.7M in revenue in Q3 2026. This represents an increase of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.

EBITDA

$191.4M

YoY+4.0%

QoQ+5.8%

5Y CAGR-18.3%

10Y CAGR+7.3%

Revvity, Inc.'s EBITDA was $191.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.0% from the same quarter a year earlier. Against the prior quarter it is up 5.8%.

Net Income

$51.8M

YoY+11.1%

QoQ+27.3%

5Y CAGR-32.8%

10Y CAGR-0.6%

Revvity, Inc. reported $51.8M in net income in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 27.3%.

EPS (Diluted)

$0.47

YoY+17.5%

QoQ+30.6%

5Y CAGR-32.6%

10Y CAGR-0.2%

Revvity, Inc. earned $0.47 per diluted share (EPS) in Q3 2026. This represents an increase of 17.5% from the same quarter a year earlier. Against the prior quarter it is up 30.6%.

Cash & Balance Sheet

Free Cash Flow

$180.9M

YoY+50.7%

QoQ+89.5%

5Y CAGR-17.0%

10Y CAGR+13.1%

Revvity, Inc. generated $180.9M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 50.7% from the same quarter a year earlier. Against the prior quarter it is up 89.5%.

Cash & Debt

$1.0B

YoY+9.8%

QoQ+18.9%

5Y CAGR+0.7%

10Y CAGR+18.0%

Revvity, Inc. held $1.0B in cash against $2.6B in long-term debt as of Q3 2026.

Dividends Per Share

$0.07

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR0.0%

Revvity, Inc. paid $0.07 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

112M

YoY-1.6%

QoQ0.0%

5Y CAGR-0.1%

10Y CAGR0.0%

Revvity, Inc. had 112M shares outstanding in Q3 2026. This represents a decrease of 1.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

57.1%

YoY+3.5pp

QoQ+2.6pp

Revvity, Inc.'s gross margin was 57.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.

Operating Margin

12.2%

YoY+0.5pp

QoQ+1.6pp

5Y change-32.0pp

10Y change-0.6pp

Revvity, Inc.'s operating margin was 12.2% in Q3 2026, reflecting core business profitability. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Net Margin

7.1%

YoY+0.4pp

QoQ+1.4pp

5Y change-29.8pp

10Y change-3.3pp

Revvity, Inc.'s net profit margin was 7.1% in Q3 2026, showing the share of revenue converted to profit. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Return on Equity

0.7%

YoY+0.1pp

QoQ+0.1pp

5Y change-8.8pp

10Y change-2.0pp

Revvity, Inc.'s ROE was 0.7% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Capital Allocation

R&D Spending

$49.0M

YoY-3.6%

QoQ-15.4%

Revvity, Inc. invested $49.0M in research and development in Q3 2026. This represents a decrease of 3.6% from the same quarter a year earlier. Against the prior quarter it is down 15.4%.

Share Buybacks

$16.0M

YoY-92.2%

QoQ-81.5%

5Y CAGR-17.9%

10Y CAGR-14.0%

Revvity, Inc. spent $16.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 92.2% from the same quarter a year earlier. Against the prior quarter it is down 81.5%.

Capital Expenditures

$11.1M

YoY-40.1%

QoQ-44.0%

5Y CAGR-5.0%

10Y CAGR+3.7%

Revvity, Inc. invested $11.1M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 40.1% from the same quarter a year earlier. Against the prior quarter it is down 44.0%.

RVTY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVTY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.9B	$2.9B+3.7%	$2.8B+0.2%	$2.8B-16.9%	$3.3B-13.5%	$3.8B+1.2%	$3.8B+31.2%	$2.9B+3.8%	$2.8B+23.1%	$2.3B+6.7%	$2.1B+0.5%	$2.1B-5.9%	$2.2B+3.7%	$2.2B+2.0%	$2.1B+10.3%	$1.9B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.4B+102.8%	$708.7M+6.6%	$664.8M-4.5%	$696.5M-1.6%	$708.0M-9.6%	$783.6M+2.7%	$763.0M+11.1%	$686.8M
Gross Profit	N/A	N/A	N/A	N/A	$2.0B-18.2%	$2.4B+15.4%	$2.1B+51.1%	$1.4B+4.1%	$1.3B+24.9%	$1.1B+6.0%	$1.0B+5.1%	$964.2M-4.0%	$1.0B+2.9%	$976.1M+1.3%	$963.2M+13.6%	$847.8M
R&D Expenses	$215.8M	$215.8M+9.7%	$196.8M-9.1%	$216.6M-2.3%	$221.6M+10.6%	$200.3M+36.8%	$146.4M-22.7%	$189.3M-2.4%	$194.0M+39.1%	$139.5M+12.3%	$124.2M+10.3%	$112.5M+4.1%	$108.1M-18.4%	$132.4M+0.4%	$131.8M+13.8%	$115.8M
SG&A Expenses	$1.0B	$991.9M-0.2%	$994.1M-2.8%	$1.0B-0.3%	$1.0B+5.2%	$975.2M+36.1%	$716.5M-12.1%	$815.3M+0.4%	$811.9M+29.7%	$626.0M+6.0%	$590.5M+0.6%	$587.2M-9.4%	$648.2M+11.4%	$581.9M-7.2%	$627.4M+0.5%	$624.4M
Operating Income	$358.8M	$356.6M+2.9%	$346.7M+15.4%	$300.6M-59.5%	$742.7M-41.0%	$1.3B+45.1%	$867.3M+139.6%	$362.0M+11.8%	$323.9M+9.6%	$295.6M+0.4%	$294.6M+17.4%	$250.9M+52.1%	$165.0M-27.6%	$227.8M+120.9%	$103.1M+13.2%	$91.1M
EBITDA	N/A	$762.0M-1.6%	$774.6M+5.8%	$732.3M-37.4%	$1.2B-25.5%	$1.6B+46.9%	$1.1B+85.6%	$576.0M+14.2%	$504.5M+25.9%	$400.6M+1.5%	$394.6M+10.7%	$356.3M+29.3%	$275.5M-22.3%	$354.7M+55.4%	$228.2M+13.0%	$202.0M
Interest Expense	$94.0M	$92.2M-4.3%	$96.3M-2.6%	$98.8M-4.9%	$104.0M	N/A	$49.7M-21.9%	$63.6M-5.0%	$67.0M+52.4%	$43.9M+5.8%	$41.5M+9.3%	$38.0M+4.8%	$36.3M-27.3%	$49.9M+9.0%	$45.8M+84.8%	$24.8M
Income Tax	$23.4M	$28.4M-14.1%	$33.1M+851.8%	$3.5M-97.5%	$139.2M-55.7%	$314.1M+85.3%	$169.5M+1705.4%	$9.4M-53.5%	$20.2M-85.5%	$139.8M+393.0%	$28.4M+41.7%	$20.0M+419.3%	-$6.3M+40.7%	-$10.6M+34.4%	-$16.1M-125.5%	$63.2M
Net Income	$237.6M	$241.2M-10.8%	$270.4M-61.0%	$693.1M+21.8%	$569.2M-39.7%	$943.2M+29.6%	$727.9M+219.9%	$227.6M-4.4%	$237.9M-18.7%	$292.6M+24.9%	$234.3M+10.3%	$212.4M+34.6%	$157.8M-5.6%	$167.2M+139.1%	$69.9M+813.7%	$7.7M
EPS (Basic)	N/A	$2.07-6.3%	$2.21-60.3%	$5.56+23.3%	$4.51-44.5%	$8.12+24.5%	$6.52+216.5%	$2.06-4.2%	$2.15-19.5%	$2.67+24.8%	$2.14+13.2%	$1.89+35.0%	$1.40-6.0%	$1.49+144.3%	$0.61+771.4%	$0.07
EPS (Diluted)	$2.09	$2.07-5.9%	$2.20-60.4%	$5.55+23.3%	$4.50-44.3%	$8.08+24.5%	$6.49+218.1%	$2.04-4.2%	$2.13-19.3%	$2.64+24.5%	$2.12+13.4%	$1.87+34.5%	$1.39-5.4%	$1.47+141.0%	$0.61+771.4%	$0.07
Diluted Shares (Avg)	N/A	117M-5.1%	123M-1.6%	125M-1.3%	126M+8.4%	117M+4.1%	112M+0.5%	112M0.0%	112M+0.6%	111M+0.5%	110M-2.6%	113M-0.4%	114M+0.2%	114M-1.2%	115M+0.9%	114M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$729.7M+4.4%	$711.1M-1.3%	$772.1M+5.9%	$698.9M+2.2%	$720.3M+4.1%	$664.8M+2.3%	$729.4M+8.7%	$684.0M-3.5%
Cost of Revenue	$312.8M-3.6%	$323.5M-1.3%	N/A	$324.3M+8.4%	$327.7M+7.0%	$289.2M-1.9%	N/A	$299.2M-2.4%
Gross Profit	$416.9M+11.3%	$387.7M-1.2%	N/A	$374.6M-2.7%	$392.6M+1.8%	$375.5M+5.8%	N/A	$384.8M-4.4%
R&D Expenses	$49.0M-3.6%	$57.9M+8.7%	$58.2M+18.2%	$50.8M+3.4%	$53.3M+10.7%	$53.6M+6.4%	$49.2M-7.2%	$49.1M-14.2%
SG&A Expenses	$278.6M+15.2%	$253.9M+2.2%	$251.7M+3.0%	$241.9M+1.8%	$248.5M-1.2%	$249.7M-4.2%	$244.3M-2.4%	$237.5M-11.0%
Operating Income	$89.3M+9.1%	$75.9M-16.4%	$111.7M-5.9%	$81.9M-16.6%	$90.8M+5.9%	$72.2M+63.7%	$118.8M+71.5%	$98.2M+25.7%
EBITDA	$191.4M+4.0%	$180.9M-6.5%	$214.8M-4.0%	$184.0M-10.6%	$193.6M+0.3%	$169.7M+11.7%	$223.8M+26.1%	$205.8M+10.1%
Interest Expense	$23.0M+1.0%	$24.7M+7.8%	$23.5M+3.2%	$22.8M-6.6%	$22.9M-7.2%	$23.0M-5.9%	$22.8M-10.6%	$24.4M-6.2%
Income Tax	$10.1M+18.7%	$9.1M-32.2%	-$4.2M-168.2%	$8.5M+21.4%	$13.4M-4.5%	$10.7M+83.0%	$6.2M-65.9%	$7.0M-46.1%
Net Income	$51.8M+11.1%	$40.7M-24.5%	$98.4M+3.9%	$46.7M-50.6%	$53.9M-2.6%	$42.2M+62.4%	$94.6M+896.6%	$94.4M+165.4%
EPS (Basic)	$0.47+17.5%	$0.36-21.7%	$0.86+10.3%	$0.40-48.1%	$0.46+2.2%	$0.35+66.7%	$0.78+875.0%	$0.77+175.0%
EPS (Diluted)	$0.47+17.5%	$0.36-21.7%	$0.86+10.3%	$0.40-48.1%	$0.46+2.2%	$0.35+66.7%	$0.78+875.0%	$0.77+175.0%
Diluted Shares (Avg)	112M-3.3%	112M-4.8%	N/A	115M-6.1%	118M-4.8%	120M-2.7%	N/A	123M-1.9%

RVTY Balance Sheet

RVTY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$12.2B-1.8%	$12.4B-8.6%	$13.6B-4.0%	$14.1B-5.8%	$15.0B+88.4%	$8.0B+21.7%	$6.5B+9.4%	$6.0B-1.9%	$6.1B+42.4%	$4.3B+2.6%	$4.2B+0.9%	$4.1B+4.6%	$3.9B+1.2%	$3.9B+1.2%	$3.9B
Current Assets	$2.2B-4.7%	$2.3B-21.7%	$3.0B-8.7%	$3.3B+34.7%	$2.4B+9.0%	$2.2B+62.9%	$1.4B+11.3%	$1.2B+2.9%	$1.2B+0.8%	$1.2B+15.2%	$1.0B-3.3%	$1.1B+2.3%	$1.0B+7.5%	$971.8M+10.0%	$883.1M
Cash & Equivalents	$919.9M-20.9%	$1.2B+27.4%	$913.2M+101.0%	$454.4M-24.7%	$603.3M+55.9%	$387.1M+101.7%	$191.9M+17.6%	$163.1M-19.3%	$202.1M-43.7%	$359.3M+51.0%	$237.9M+36.1%	$174.8M0.0%	$174.8M+0.9%	$173.2M+21.7%	$142.3M
Short-Term Investments	$0	$0-100.0%	$689.9M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$379.5M+3.2%	$367.6M-14.1%	$428.1M+5.6%	$405.5M-4.8%	$425.9M-17.2%	$514.6M+44.2%	$356.9M+5.5%	$338.3M-3.8%	$351.7M+42.5%	$246.8M-4.9%	$259.5M-9.1%	$285.5M+9.4%	$260.9M+5.3%	$247.7M+2.9%	$240.8M
Accounts Receivable	$744.7M+17.8%	$632.4M-0.1%	$632.8M+3.3%	$612.8M-13.4%	$707.9M-38.7%	$1.2B+59.3%	$725.2M+14.6%	$632.7M+14.6%	$552.3M+29.8%	$425.6M+2.5%	$415.1M-11.8%	$470.6M+0.8%	$466.7M+2.1%	$457.0M+11.5%	$409.9M
Long-Term Investments	$28.0M+2.0%	$27.4M+97.0%	$13.9M+25.5%	$11.1M-67.1%	$33.7M+1463.7%	$2.2M-25.9%	$2.9M+18.8%	$2.4M+10.8%	$2.2M+31.6%	$1.7M+5.8%	$1.6M+1.1%	$1.6M+18.9%	$1.3M+14.8%	$1.1M+4.0%	$1.1M
Goodwill	$6.6B+2.3%	$6.5B-1.1%	$6.5B+0.8%	$6.5B-2.2%	$6.6B+151.1%	$2.6B-15.2%	$3.1B+5.4%	$3.0B-1.7%	$3.0B+33.6%	$2.2B+0.5%	$2.2B-0.3%	$2.2B+4.7%	$2.1B+1.0%	$2.1B+1.4%	$2.1B
Total Liabilities	$4.9B+4.1%	$4.7B-17.0%	$5.7B-15.6%	$6.7B-14.2%	$7.9B+86.0%	$4.2B+13.4%	$3.7B+9.9%	$3.4B-5.5%	$3.6B+69.0%	$2.1B+3.3%	$2.1B-1.4%	$2.1B+6.8%	$2.0B-0.5%	$2.0B-2.6%	$2.0B
Current Liabilities	$1.3B+103.8%	$653.1M-55.0%	$1.5B-6.1%	$1.5B+27.2%	$1.2B-26.5%	$1.7B+116.6%	$762.8M-1.1%	$771.6M-18.9%	$950.9M+57.6%	$603.4M+7.5%	$561.5M-6.0%	$597.3M-0.9%	$602.8M+3.7%	$581.1M-2.9%	$598.7M
Non-Current Liabilities	$3.6B-11.9%	$4.1B-4.0%	$4.2B-18.5%	$5.2B-21.7%	$6.6B+158.3%	$2.6B-13.1%	$3.0B+13.1%	$2.6B-0.7%	$2.6B+73.5%	$1.5B+1.7%	$1.5B+0.4%	$1.5B+10.3%	$1.3B-2.3%	$1.4B-2.4%	$1.4B
Long-Term Debt	$2.6B-16.5%	$3.2B-0.9%	$3.2B-19.0%	$3.9B-21.2%	$5.0B+209.4%	$1.6B-22.0%	$2.1B+10.0%	$1.9B+4.9%	$1.8B+71.1%	$1.0B+3.3%	$1.0B-3.2%	$1.0B+12.2%	$932.1M-0.7%	$938.8M-0.6%	$944.9M
Total Equity	$7.3B-5.4%	$7.7B-2.6%	$7.9B+6.6%	$7.4B+3.4%	$7.1B+91.2%	$3.7B+32.8%	$2.8B+8.9%	$2.6B+3.3%	$2.5B+16.2%	$2.2B+2.0%	$2.1B+3.3%	$2.0B+2.4%	$2.0B+2.8%	$1.9B+5.3%	$1.8B
Retained Earnings	$6.1B+3.6%	$5.8B+4.2%	$5.6B+13.3%	$5.0B+12.1%	$4.4B+25.9%	$3.5B+24.7%	$2.8B+8.1%	$2.6B+9.3%	$2.4B+12.4%	$2.1B+6.4%	$2.0B+10.0%	$1.8B+7.5%	$1.7B+8.8%	$1.5B+2.5%	$1.5B

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$12.0B-0.8%	$12.0B-3.0%	$12.2B-1.8%	$12.1B-4.9%	$12.4B-7.9%	$12.4B-8.0%	$12.4B-7.7%	$12.8B-10.2%
Current Assets	$2.3B+7.2%	$2.1B-4.8%	$2.2B-4.7%	$2.1B-12.4%	$2.2B-29.2%	$2.3B-24.2%	$2.3B-19.3%	$2.4B-30.5%
Cash & Equivalents	$1.0B+9.8%	$860.3M-13.3%	$919.9M-20.9%	$931.4M-24.3%	$991.8M-20.5%	$1.1B+14.0%	$1.2B+2.3%	$1.2B-7.7%
Short-Term Investments	$0	$0	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%
Inventory	$378.5M-0.4%	$387.5M-0.2%	$379.5M+3.2%	$379.9M-6.1%	$388.5M-3.2%	$381.3M-7.9%	$367.6M-15.6%	$404.6M-7.4%
Accounts Receivable	$709.2M+4.3%	$691.4M+4.6%	$744.7M+17.8%	$680.3M+13.0%	$661.1M+10.7%	$617.4M+4.8%	$632.4M-1.9%	$602.1M-4.0%
Long-Term Investments	$0	$0	$28.0M+2.0%	$0	$0	$0	$27.4M	$0
Goodwill	$6.6B+0.1%	$6.6B-0.1%	$6.6B+2.3%	$6.6B+0.6%	$6.6B+1.8%	$6.5B+0.1%	$6.5B-0.1%	$6.6B+0.6%
Total Liabilities	$4.8B+1.1%	$4.8B+0.2%	$4.9B+4.1%	$4.8B-1.8%	$4.8B-13.5%	$4.7B-15.4%	$4.7B-17.5%	$4.8B-23.6%
Current Liabilities	$1.3B+4.4%	$1.2B+84.4%	$1.3B+103.8%	$1.2B+77.7%	$671.8M-51.7%	$648.2M-52.8%	$653.1M-54.9%	$687.9M-49.7%
Non-Current Liabilities	$3.5B0.0%	$3.6B-13.5%	$3.6B-11.9%	$3.5B-14.9%	$4.1B-0.7%	$4.1B-3.2%	$4.1B-4.8%	$4.2B-16.5%
Long-Term Debt	$2.6B+0.1%	$2.6B-18.1%	$2.6B-16.5%	$2.6B-17.4%	$3.2B+1.6%	$3.2B+0.1%	$3.2B-0.1%	$3.2B-18.0%
Total Equity	$7.2B-2.0%	$7.2B-4.9%	$7.3B-5.4%	$7.4B-6.9%	$7.6B-4.0%	$7.6B-2.7%	$7.7B-0.4%	$7.9B+0.7%
Retained Earnings	$6.1B+2.8%	$6.1B+2.7%	$6.1B+3.6%	$6.0B+3.6%	$5.9B+4.4%	$5.9B+4.5%	$5.8B+5.5%	$5.8B+4.0%

RVTY Cash Flow Statement

RVTY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$627.6M	$582.9M-7.2%	$628.3M+588.4%	$91.3M-86.6%	$679.8M-51.8%	$1.4B+58.1%	$892.2M+145.5%	$363.5M+16.9%	$311.0M+7.8%	$288.5M-17.7%	$350.6M+22.1%	$287.1M+2.0%	$281.6M+77.6%	$158.6M+4.2%	$152.2M-32.3%	$224.9M
Depreciation & Amortization	N/A	$405.3M-5.3%	$427.8M-0.9%	$431.8M+1.1%	$427.0M+37.1%	$311.4M+54.4%	$201.6M-5.8%	$214.0M+18.5%	$180.6M+72.0%	$105.0M+5.0%	$100.0M-5.1%	$105.4M-4.6%	$110.5M-12.9%	$126.9M+1.4%	$125.1M+12.8%	$110.9M
Stock-Based Compensation	N/A	$22.8M-39.6%	$37.8M-8.7%	$41.4M-19.6%	$51.5M+73.6%	$29.7M+10.3%	$26.9M-14.6%	$31.5M+9.5%	$28.8M+13.2%	$25.4M+48.2%	$17.2M-0.7%	$17.3M+22.9%	$14.1M0.0%	$14.1M-31.9%	$20.6M+33.2%	$15.5M
Capital Expenditures	$69.5M	$73.5M-15.1%	$86.6M+6.5%	$81.4M-5.0%	$85.6M-0.5%	$86.0M+35.2%	$63.6M-16.6%	$76.3M-18.1%	$93.3M+138.6%	$39.1M+23.3%	$31.7M+12.3%	$28.2M+3.9%	$27.2M-30.3%	$39.0M-8.1%	$42.4M+38.6%	$30.6M
Free Cash Flow	$558.1M	$509.4M-6.0%	$541.7M+5369.0%	$9.9M-98.3%	$594.2M-55.1%	$1.3B+59.9%	$828.5M+188.6%	$287.1M+31.8%	$217.8M-12.7%	$249.4M-21.8%	$318.9M+23.2%	$258.9M+1.7%	$254.4M+112.7%	$119.6M+9.0%	$109.8M-43.5%	$194.3M
Investing Cash Flow	-$83.3M	-$17.4M-102.2%	$776.2M-40.9%	$1.3B+1088.7%	-$132.9M+96.8%	-$4.1B-715.2%	-$504.5M-3.5%	-$487.6M-205.0%	-$159.9M+87.4%	-$1.3B-1409.9%	-$83.9M+16.8%	-$100.9M+65.9%	-$295.9M-24334.1%	-$1.2M+98.5%	-$80.3M+91.2%	-$909.9M
Financing Cash Flow	-$503.4M	-$857.5M+24.0%	-$1.1B-19.1%	-$947.1M-43.1%	-$661.8M-122.5%	$2.9B+1550.0%	-$202.9M-35.1%	-$150.1M+16.2%	-$179.2M-122.9%	$782.2M+780.1%	-$115.0M-7.3%	-$107.1M-446.4%	$30.9M+120.1%	-$154.2M-249.1%	-$44.2M-111.1%	$397.2M
Dividends Paid	$31.6M	$32.8M-4.8%	$34.5M-1.5%	$35.0M-1.1%	$35.3M+9.2%	$32.4M+3.7%	$31.2M+0.5%	$31.1M+0.2%	$31.0M+0.7%	$30.8M0.0%	$30.8M-2.4%	$31.6M-0.2%	$31.6M+0.1%	$31.6M-0.9%	$31.9M+0.2%	$31.8M
Share Buybacks	$475.8M	$820.8M+122.1%	$369.6M-5.0%	$388.9M+382.3%	$80.6M+10.4%	$73.1M+952.3%	$6.9M+10.0%	$6.3M-89.0%	$57.4M+1398.3%	$3.8M-97.5%	$151.8M+98.6%	$76.4M+16.6%	$65.5M-48.6%	$127.4M+5955.0%	$2.1M-98.1%	$110.0M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$191.9M+38.6%	$115.2M-14.2%	$182.0M+4.4%	$138.5M-6.3%	$134.3M-15.3%	$128.2M-13.2%	$174.2M+620.3%	$147.9M+209.3%
Depreciation & Amortization	$102.1M0.0%	$105.1M+2.2%	$103.1M-1.9%	$102.1M-5.2%	$102.8M-4.2%	$97.4M-9.6%	$105.0M-3.0%	$107.6M-1.2%
Stock-Based Compensation	N/A	$8.7M	N/A	N/A	N/A	$7.7M-33.9%	N/A	N/A
Capital Expenditures	$11.1M-40.1%	$19.8M+4.8%	$20.2M-17.5%	$18.5M-17.1%	$18.9M-14.4%	$16.0M-10.4%	$24.5M+9.4%	$22.3M+60.0%
Free Cash Flow	$180.9M+50.7%	$95.5M-17.3%	$161.8M+8.0%	$120.0M-4.4%	$115.5M-15.5%	$112.2M-13.5%	$149.8M+368.2%	$125.6M+184.1%
Investing Cash Flow	-$3.5M-118.5%	-$78.3M-724.5%	-$20.5M-18.0%	$19.0M-97.3%	-$9.5M-107.8%	-$6.4M+64.9%	-$17.3M-104.0%	$690.2M+220.9%
Financing Cash Flow	-$23.2M+89.2%	-$88.9M+70.6%	-$176.3M+8.6%	-$215.1M+75.4%	-$302.5M-1041.6%	-$163.7M-367.4%	-$193.0M+67.1%	-$873.7M-282.8%
Dividends Paid	$7.8M-1.9%	$7.8M-2.8%	$8.0M-6.8%	$8.0M-6.7%	$8.1M-6.7%	$8.4M-2.4%	$8.5M-0.9%	$8.5M-1.6%
Share Buybacks	$16.0M-92.2%	$86.5M-70.6%	$168.3M-9.1%	$205.0M+33.0%	$293.9M+1403.1%	$153.6M+1328.0%	$185.2M+67.2%	$154.1M-27.2%

RVTY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVTY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	60.1%-3.5pp	63.6%+7.8pp	55.8%+7.4pp	48.4%+0.1pp	48.3%+0.7pp	47.6%-0.3pp	47.9%+2.1pp	45.8%+0.9pp	44.9%-0.3pp	45.2%-0.3pp	45.5%+1.4pp	44.2%
Operating Margin	12.5%-0.1pp	12.6%+1.7pp	10.9%-11.5pp	22.4%-10.4pp	32.9%+9.9pp	22.9%+10.4pp	12.6%+0.9pp	11.7%-1.4pp	13.1%-0.8pp	13.9%+2.0pp	11.9%+4.5pp	7.4%-3.2pp	10.6%+5.7pp	4.9%+0.1pp	4.8%
Net Margin	8.5%-1.4pp	9.8%-15.4pp	25.2%+8.0pp	17.2%-7.5pp	24.6%+5.4pp	19.2%+11.3pp	7.9%-0.7pp	8.6%-4.4pp	13.0%+1.9pp	11.1%+1.0pp	10.1%+3.0pp	7.0%-0.7pp	7.8%+4.4pp	3.3%+2.9pp	0.4%
Return on Equity	3.3%-0.2pp	3.5%-5.3pp	8.8%+1.1pp	7.7%-5.5pp	13.2%-6.3pp	19.5%+11.4pp	8.1%-1.1pp	9.2%-2.5pp	11.7%+0.8pp	10.9%+0.8pp	10.1%+2.3pp	7.7%-0.7pp	8.4%+4.8pp	3.6%+3.2pp	0.4%
Return on Assets	2.0%-0.2pp	2.2%-2.9pp	5.1%+1.1pp	4.0%-2.3pp	6.3%-2.8pp	9.1%+5.7pp	3.5%-0.5pp	4.0%-0.8pp	4.8%-0.7pp	5.5%+0.4pp	5.1%+1.3pp	3.8%-0.4pp	4.2%+2.5pp	1.8%+1.6pp	0.2%
Current Ratio	1.68-1.9x	3.60+1.5x	2.07-0.1x	2.13+0.1x	2.01+0.7x	1.36-0.4x	1.80+0.2x	1.60+0.3x	1.26-0.7x	1.97+0.1x	1.84+0.1x	1.79+0.1x	1.73+0.1x	1.67+0.2x	1.48
Debt-to-Equity	0.360.0x	0.410.0x	0.40-0.1x	0.53-0.2x	0.70+0.3x	0.43-0.3x	0.730.0x	0.730.0x	0.71+0.2x	0.490.0x	0.480.0x	0.510.0x	0.470.0x	0.480.0x	0.51
Asset Turnover	0.230.0x	0.220.0x	0.200.0x	0.230.0x	0.26-0.2x	0.480.0x	0.440.0x	0.46+0.1x	0.37-0.1x	0.490.0x	0.510.0x	0.540.0x	0.550.0x	0.540.0x	0.50
FCF Margin	17.8%-1.8pp	19.7%+19.3pp	0.4%-17.6pp	17.9%-16.7pp	34.6%+12.7pp	21.9%+11.9pp	10.0%+2.1pp	7.8%-3.2pp	11.1%-4.0pp	15.1%+2.8pp	12.3%+0.9pp	11.4%+5.8pp	5.5%+0.3pp	5.2%-4.9pp	10.1%

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	57.1%+3.5pp	54.5%0.0pp	N/A	53.6%-2.7pp	54.5%-1.2pp	56.5%+1.9pp	N/A	56.3%-0.5pp
Operating Margin	12.2%+0.5pp	10.7%-1.9pp	14.5%-1.8pp	11.7%-2.6pp	12.6%+0.2pp	10.9%+4.1pp	16.3%+6.0pp	14.3%+3.3pp
Net Margin	7.1%+0.4pp	5.7%-1.8pp	12.7%-0.2pp	6.7%-7.1pp	7.5%-0.5pp	6.3%+2.4pp	13.0%+11.6pp	13.8%+8.8pp
Return on Equity	0.7%+0.1pp	0.6%-0.1pp	1.4%+0.1pp	0.6%-0.6pp	0.7%0.0pp	0.5%+0.2pp	1.2%+1.1pp	1.2%+0.7pp
Return on Assets	0.4%+0.1pp	0.3%-0.1pp	0.8%0.0pp	0.4%-0.4pp	0.4%0.0pp	0.3%+0.1pp	0.8%+0.7pp	0.7%+0.5pp
Current Ratio	1.800.0x	1.72-1.6x	1.68-1.9x	1.75-1.8x	3.33+1.1x	3.58+1.3x	3.60+1.6x	3.56+1.0x
Debt-to-Equity	0.360.0x	0.37-0.1x	0.360.0x	0.360.0x	0.430.0x	0.410.0x	0.410.0x	0.40-0.1x
Asset Turnover	0.060.0x	0.060.0x	0.060.0x	0.060.0x	0.060.0x	0.050.0x	0.060.0x	0.050.0x
FCF Margin	24.8%+7.6pp	13.4%-2.6pp	21.0%+0.4pp	17.2%-1.2pp	16.0%-3.7pp	16.9%-3.1pp	20.5%+28.9pp	18.4%+39.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Revvity, Inc. RVTY	FY2025	$2.9B	$241.2M	8.5%	$17.4B	51/100
QIAGEN N.V. QGEN	FY2025	$2.1B	$424.9M	20.3%	$9.4B	65/100
Charles River Laboratories International, Inc. CRL	FY2025	$4.0B	-$144.3M	-3.6%	$14.4B	40/100
Guardant Health, Inc. GH	FY2025	$982.0M	-$416.3M	-42.4%	$22.5B	63/100
RadNet, Inc. RDNT	FY2025	$2.0B	-$18.6M	-0.9%	$5.6B	44/100
Sotera Health Company SHC	FY2025	$1.2B	$77.9M	6.7%	$5.2B	57/100

Where Revvity, Inc. Ranks

Frequently Asked Questions

What is Revvity, Inc.'s annual revenue?

Revvity, Inc. (RVTY) reported $2.9B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Revvity, Inc.'s revenue growing?

Revvity, Inc. (RVTY) revenue grew by 3.7% year-over-year, from $2.8B to $2.9B in fiscal year 2025.

Is Revvity, Inc. profitable?

Yes, Revvity, Inc. (RVTY) reported a net income of $241.2M in fiscal year 2025, with a net profit margin of 8.5%.

What is Revvity, Inc.'s EBITDA?

Revvity, Inc. (RVTY) had EBITDA of $762.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Revvity, Inc. have?

As of fiscal year 2025, Revvity, Inc. (RVTY) had $919.9M in cash and equivalents against $2.6B in long-term debt.

What is Revvity, Inc.'s operating margin?

Revvity, Inc. (RVTY) had an operating margin of 12.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Revvity, Inc.'s net profit margin?

Revvity, Inc. (RVTY) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Revvity, Inc. pay dividends?

Yes, Revvity, Inc. (RVTY) paid $0.28 per share in dividends during fiscal year 2025.

What is Revvity, Inc.'s return on equity (ROE)?

Revvity, Inc. (RVTY) has a return on equity of 3.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Revvity, Inc.'s free cash flow?

Revvity, Inc. (RVTY) generated $509.4M in free cash flow during fiscal year 2025. This represents a -6.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Revvity, Inc.'s operating cash flow?

Revvity, Inc. (RVTY) generated $582.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Revvity, Inc.'s total assets?

Revvity, Inc. (RVTY) had $12.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Revvity, Inc.'s capital expenditures?

Revvity, Inc. (RVTY) invested $73.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Revvity, Inc. spend on research and development?

Revvity, Inc. (RVTY) invested $215.8M in research and development during fiscal year 2025.

Does Revvity, Inc. buy back shares?

Yes, Revvity, Inc. (RVTY) spent $820.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Revvity, Inc. have outstanding?

Revvity, Inc. (RVTY) had 112M shares outstanding as of fiscal year 2025.

What is Revvity, Inc.'s current ratio?

Revvity, Inc. (RVTY) had a current ratio of 1.68 as of fiscal year 2025, which is generally considered healthy.

What is Revvity, Inc.'s debt-to-equity ratio?

Revvity, Inc. (RVTY) had a debt-to-equity ratio of 0.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Revvity, Inc.'s return on assets (ROA)?

Revvity, Inc. (RVTY) had a return on assets of 2.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Revvity, Inc.'s P/E ratio?

Revvity, Inc. (RVTY) trades at 73.1x earnings, its market capitalization divided by net income of $237.6M net income, trailing 12 months to July 5, 2026. The market capitalization is $17.4B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Revvity, Inc.'s price-to-sales ratio?

Revvity, Inc. (RVTY) trades at 6.0x sales, its market capitalization divided by revenue of $2.9B revenue, trailing 12 months to July 5, 2026. The market capitalization is $17.4B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Revvity, Inc.'s Altman Z-Score?

Revvity, Inc. (RVTY) has an Altman Z-Score of 3.24, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Revvity, Inc.'s Piotroski F-Score?

Revvity, Inc. (RVTY) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Revvity, Inc.'s earnings high quality?

Revvity, Inc. (RVTY) has an earnings quality ratio of 2.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Revvity, Inc. cover its interest payments?

Revvity, Inc. (RVTY) has an interest coverage ratio of 3.87x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Revvity, Inc.?

Revvity, Inc. (RVTY) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.